Nath Bio-Genes (India) Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 225.68 million compared to INR 217.29 million a year ago. Revenue was INR 225.68 million compared to INR 217.29 million a year ago. Net income was INR 20.34 million compared to INR 14.69 million a year ago. Basic earnings per share from continuing operations was INR 0.86 compared to INR 0.77 a year ago.
For the six months, sales was INR 2,578.49 million compared to INR 2,310.79 million a year ago. Revenue was INR 2,578.49 million compared to INR 2,310.79 million a year ago. Net income was INR 351.05 million compared to INR 322.26 million a year ago. Basic earnings per share from continuing operations was INR 18.27 compared to INR 16.96 a year ago.